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Macrophages play a major role in HIV-1 persistence. In the present paper, we demonstrate that the absence of apoptosis in HIV-1-infected
primary human monocyte-differentiated macrophages (MDM) correlates with an increase in anti-apoptotic (Bcl-2 and Bcl-xL) and a decrease
in pro-apoptotic (Bax and Bad) proteins. This is associated with macrophage activation as shown by tumor necrosis factor (TNF) production
and NF-nB activation upon infection. TNF production was shown to be involved in the upregulation of Bcl-2 and Bcl-xL because this
increase was abolished by an anti-TNF anti-serum or an inhibitor of TNF synthesis. In parallel, inhibition of TNF production induced an
increase in the number of apoptotic cells. Furthermore, using an inhibitor of NF-nB activation, we demonstrated that TNF-induced
upregulation of Bcl-xL and Bcl-2 occurs, respectively, through a NF-nB-dependent and an NF-nB-independent pathway.
D 2004 Elsevier Inc. All rights reserved.
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Macrophages, a main non-T-cell reservoir for HIV
(Gartner et al., 1986), are sites of infection in several organs
and particularly in the brain, and play a critical role in HIV
pathogenesis (Collman et al., 2003). Studies performed both
in human patients and in an animal model show that at a late
stage of infection, macrophages constitute a major source of
virus in lymphoid tissues of HIV-infected patients (Oren-
stein et al., 1997) or in simian immunodeficiency virus/HIV-
1 chimera (SHIV)-infected macaques (Igarashi et al., 2001).
In particular, several studies demonstrated the capacity of
infected macrophages to induce apoptosis in both CD4 and
CD8 T lymphocytes (Mahlknecht and Herbein, 2001).
Therefore, HIV persistence in macrophages plays a key
role in virus spreading and disease progression.0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: nisrael@pasteur.fr (N. IsraJl).Furthermore, monocytes or macrophages behave as a
reservoir refractory to antiretroviral treatment. In patients,
under prolonged HAART, exhibiting undetectable periph-
eral viral load, HIV-DNA was found in monocytes and
viral production can be activated in these cells by diverse
bacterial products (Lambotte et al., 2000). This is
consistent with the fact that antiretrovirals including
protease inhibitors have been shown in vitro to be less
active in chronically HIV-infected macrophages than in
lymphocytes (Crowe et al., 1989; Perno et al., 1998). The
molecular mechanisms that regulate the effects of HIV
infection are different in T cells and macrophages. Upon
HIV infection, whereas apoptosis has been proposed as a
crucial mechanism of T cell destruction (Selliah and
Finkel, 2001), resistance to virus-induced cell death was
shown to be a key feature of macrophages. However, the
mechanisms involved in the survival capacity of HIV-
infected macrophages resulting in sustained viral persis-
tence are not currently understood. Key arguments are
provided by observations made on T lymphocytes. For
instance, in HIV-infected patients, Bcl-2 expression was04) 371–380
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1999) and CD8 T cells (Boudet et al., 1996; Regamey et al.,
1999) correlating with a higher propensity of these cells to
undergo spontaneous apoptosis in culture (Akari et al.,
2001). Several in vitro studies carried out in primary cells
or lymphocytic cell lines also described an increase of
production of the pro-apoptotic protein Bax (Castedo et al.,
2001; Genini et al., 2001). We therefore hypothesized that
HIV infection induces an increase of anti-apoptotic and a
decrease of pro-apoptotic proteins of the Bcl-2 family to
strengthen the survival capacity of macrophages. Indeed, in
a previous report, we showed that HIV infection induces an
upregulation of Bcl-2 at the transcriptional level in
monocytic U 937 cells and that this increase in Bcl-2
synthesis correlates with cell survival (Aillet et al., 1998).
We also showed that downregulation of Bcl-2 in blood
monocytes from HIV-infected patients was observed during
the asymptomatic phase of infection followed by a gradual
increase of Bcl-2 levels in the late stage of the disease
(Elbim et al., 1999).
HIV infection is characterized by a general state of
immune activation as shown by the increase of expression
of multiple factors or markers of activation in T cells and
monocytes or macrophages (Gougeon et al., 2000;
Herbein and O’Brien, 2000). In particular, tumor necrosis
factor (TNF) as well as soluble receptors TNF-R2 was
found to be produced at high levels in the serum of HIV-
infected patients (Herbein and O’Brien, 2000). Peripheral
blood monocytes were reported as a possible source of
TNF production because these cells isolated from AIDS
patients were shown to spontaneously release TNF
(Wright et al., 1988). In vitro, infection by HIV-1 induces
TNF production in monocyte-derived macrophages
(MDMs) (Godard and Chermann, 1998; Le Naour et al.,
1994a; Weissman et al., 1994). In addition, the tran-
scription factor NF-nB is activated upon HIV infection in
both monocytic cells and primary macrophages (Choe et
al., 2002; Mc Elhinny et al., 1995). Furthermore, several
reports clearly demonstrate that NF-nB activity prevents
apoptosis in various cellular models, including lympho-
cytic and macrophagic cell types (Beg and Baltimore,
1996; Van Antwerp et al., 1996; Wang et al., 1996, 1998;
You et al., 2001). Therefore, TNF-induced NF-nB activity
during HIV infection might be involved in inhibition of
apoptosis and survival of macrophages. One of the
mechanisms involved in this protective activity might be
the induction of expression of the anti-apoptotic proteins
of the Bcl-2 family. Consistent with this, an NF-nB-
dependent TNF-induced production of anti-apoptotic
factors such as Bcl-x (Chen et al., 2000; Cheng et al.,
2000; Tamatani et al., 1999) or Bfl-1/A1 (Cheng et al.,
2000) was reported in various animal or human cell types.
In addition, Bcl-2 was also described as a TNF-inducible
protein (Burgmaier et al., 2000; Genestier et al., 1995;
Tamatani et al., 1999), possibly involving a NF-nB-
dependent mechanism (Tamatani et al., 1999).In the present paper we investigated the modulation of
pro- and anti-apoptotic molecules of the Bcl-2 family in
blood monocyte-derived macrophages (MDMs) upon HIV
infection. We demonstrate that infection induces macro-
phage activation through TNF and NF-nB and leads to a
particular status of Bcl-2-related molecules, a key determi-
nant of HIV persistence in these cells.Results
HIV-1 infection does not induce apoptosis or cytotoxicity in
macrophages
A small number of apoptotic MDMs (less than 3%) was
detected among control cells, and this rate was not modified
among infected cells. Indeed, no variation of DNA con-
densation or production of nuclear apoptotic bodies was seen
after staining with Hoechst dye in cells infected with HIV-
1BaL or HIV-1BXO8 (see the curves of p24 observed with HIV-
1BaL in Fig. 1, panel c). In addition, HIV infection did not
induce any DNA fragmentation as measured by TUNEL
analysis (data not shown). Furthermore,Western blot analysis
of Caspase-3, a terminal protease of the caspase cascade,
revealed no variation of the amount of the procaspase form
p32 upon infection in MDMs, and we did not detect any
production of the p11 and p20 peptides normally generated
by the cleavage necessary for the induction of Caspase-3
activity (data not shown). Likewise, no cytotoxicity was
detected upon infection as assessed by titration of the release
of lactate dehydrogenase in the supernatants of MDMs (data
not shown). These results confirmed survival of infected
MDMs in our experimental conditions.
Bcl-2 and Bcl-xL expressions are increased in macrophages
upon HIV-1 infection
In parallel experiments, we measured the expression
level of the anti-apoptotic factors Bcl-2 and Bcl-xL in
MDMs. Data derived from control and infected cells,
although coming from the same Western blot, were
presented separately in panels A and B of Fig. 1 to
facilitate comparison of the kinetics of expression of these
molecules under control or infection conditions. We first
observed that adherence of monocytes to plastic transiently
induced an increase in Bcl-2 and Bcl-xL expression (data
not shown). This induction was still present for Bcl-2 when
the cells had differentiated into macrophages at J0
(corresponding to 7 days post adherence of monocytes)
as shown in Fig. 1Aa. In control cells, Bcl-2 and Bcl-xL
returned to basal level whereas infection transiently
induced higher expression levels (Figs. 1Aa and Ba). In
the five assays presented in Fig. 1Ab, densitometric
analysis showed an increase of Bcl-2 expression that
reached a maximum level between 10 and 18 days of
infection with a 2- to 22-fold increase (median = 5 for five
Fig. 1. Effect of HIV-1 infection on Bcl-2 (panel A) and Bcl-xL (panel B)
expression in MDMs. MDMs were left uninfected (control) or were
infected by HIV-1BaL at day 0 and analyzed for Bcl-2 or Bcl-xL expression
and viral production during 20 or 22 days. Western blot analysis of Bcl-2
(panel Aa) and Bcl-xL (panel Ba) in control and infected MDMs was
performed in comparison with h-Actin as a protein of constant expression.
Fold increase of the expression of Bcl-2 (panel Ab) and Bcl-xL (panel Bb)
upon infection was measured by densitometric analysis. Viral production
was determined by titration of p24 in cell supernatants (panel c). For panels
b and c, curves correspond to kinetics of infection performed with cells
from five different donors. Symbols used in both panels refer to the same
donors. The data used in panel a correspond to the circle symbol in panels b
and c for Bcl-2, and to the diamond symbol for Bcl-xL.
Fig. 2. Effect of HIV-1 infection on Bax (panel A) and Bad (panel B)
expression in MDMs. MDMs were left uninfected (control) or were
infected by HIV-1BaL at day 0 and analyzed for Bax or Bad expression and
viral production during 19 or 20 days. Western blot analysis of Bax (panel
Aa) and Bad (panel Ba) in control and infected MDMs was performed in
comparison with h-Actin as a protein of constant expression. Fold decrease
of the expression of Bax (panel Ab) and Bad (panel Bb) upon infection was
measured by densitometric analysis. Viral production was determined by
titration of p24 in cell supernatants (panel c). For panels b and c, curves
correspond to kinetics of infection performed with cells from three different
donors for Bax and five different donors for Bad. Symbols used in both
panels refer to the same donors. The data used in panel a correspond to the
triangle symbols in panels b and c for Bax, and to the circle symbols for
Bad.
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those of control cells at least up to 3 weeks postinfection.
These results were obtained with the HIV-1BaL strain, but
the same conclusion was made when infection was
performed using the primary isolate HIV-1BXO8 (data not
shown). In this case, fold increase of Bcl-2 upon infection
albeit significant (2–3.2) was lower than that observed with
HIV-1BaL infection. For this reason and to emphasize the
response, we used the HIV-1BaL strain for the rest of the
experiments.
Bcl-xL expression increased upon infection (Fig. 1Bb)
with a 2.9- to 28.3-fold increase ratio at the peak ofexpression (median = 6.9 for five assays) (Fig. 1Bb). Bcl-
xL expression also tended to decrease after prolonged
kinetics of infection. In parallel, virus production was
evaluated by p24 titration and this production reached a
plateau especially at longer times of infection (Figs. 1Ac
and Bc). It is interesting to stress that for short times of
infection (1 or 2 days), for which no p24 production was
detectable, we did not observe any increase of production
of the proteins Bcl-2 and Bcl-xL in infected macrophages
(data not shown). The evolution of the slope of p24
(between day 0 and 6) correlates with the evolution of the
levels of Bcl-2 or Bcl-xL, emphasizing the role of infection
in the modulation of Bcl-2 proteins. Therefore, this
increase only starts with the onset of HIV production,
thus precluding possible effects of proteins contained in
the viral stock solutions. Increase of expression of anti-
E. Guillemard et al. / Virology 329 (2004) 371–380374apoptotic factors occurred early during infection, being
detected at the first time point (day 4), when viral
production was still limited (maximum of 1 ng/ml of
p24). Similar results were obtained with MDMs differ-
entiated in the presence of M-CSF and 15% FCS instead
of human SAB (data not shown).
In conclusion, the absence of apoptosis under HIV
infection correlated with an upregulation of the anti-
apoptotic factors Bcl-2 and Bcl-xL.
Bax and Bad expressions are decreased in MDMs upon
HIV-1 infection
In parallel, we also investigated the modulation of pro-
apoptotic members of the Bcl-2 family by HIV-1 infection in
MDMs. Our data clearly show that Bax expression decreased
during infection (Figs. 2Aa and b) and then gradually
increased toward levels observed in control cells. Bax
expression reached a minimum that was 5.7–50 times lower
in infectedMDMs than in control cells (median = 10 for three
assays). Similarly, Bad expression was reduced upon HIV
infection in MDMs (Figs. 2Ba and b) with a fold decrease
ratio from 3 to 38.8 (median = 6.5 for six assays). Similar to
the modulation of anti-apoptotic factors, the decrease of both
Bax and Bad expression generally started early during
infection when viral production was still at 1 ng of p24 per
milliliters or below (Figs. 2Ac and Bc). Analyses of Bcl-xs
expression in five independent experiments showed that this
truncated pro-apoptotic form of Bcl-xL was produced neither
in control nor in infected MDMs (data not shown).
Increased expression of anti-apoptotic factors upon HIV-1
infection correlates with the induction of NF-kB activity
and TNF production
In a previous study, we demonstrated that differentiation
of thymocytes into mature single-positive CD4 cellsFig. 3. Effect of HIV-1 infection on NF-nB activity in MDMs. MDMs were left u
NF-nB activity and viral production during 20 days. (A) Analysis of NF-nB by E
controlled by competition with a cold DNA probe as described in Materials and
measured by densitometric analysis of p50–p65 band level. (C) Viral production w
correspond to kinetics of infection performed with cells from five different donor
panel A correspond to the cross symbol in panels B and C.conferred to these cells a high capacity to survive HIV-1
infection in the thymus (Guillemard et al., 2001). This
capacity correlates with both a high basal level of Bcl-2
production, which is further increased by infection, and a
high level of NF-nB activity, which is under the control of
TNF released into the thymic microenvironment (Cheˆne et
al., 1999a, 1999b; Guillemard et al., 2001). Thus, a similar
correlation could be envisioned in macrophages. Therefore,
we investigated the activation level of MDMs under
control and HIV-1 infection conditions by measuring
kinetics of both NF-nB activity and TNF production. We
first observed that the adherence of monocytes to plastic
induced a transient cellular activation with an induction of
NF-nB activity (data not shown) and of TNF secretion
(between 30 and 45 pg/ml). As shown in Fig. 3A by
EMSA analysis, control-differentiated macrophages still
exhibited a strong NF-nB activity (p50–p65 heterodimer),
which gradually decreased during culture. By comparison,
in infected cells, we observed a higher level of NF-nB
activity at each time point of the kinetics (Fig. 3A),
indicating a reinduction of NF-nB activity. As shown by
densitometric analysis, this increase was followed by a
decrease toward control values after 2–3 weeks post-
infection (Fig. 3B). At the highest levels of induction, NF-
nB activity was 2–7.6 higher upon infection than in control
conditions (median = 3.7 for five assays). In parallel,
titration by ELISA in culture supernatants showed con-
stitutive production of TNF in MDMs that gradually
decreased with time (Fig. 4). Here also HIV-infection
triggered a TNF increase mostly in the first days of
infection. Therefore, NF-nB activity could be directly
related to TNF secretion. Thus activation of MDMs was
further increased upon HIV-infection. Because the kinetics
of cellular activation correlated with the modulations of
Bcl-2 and Bcl-xL in infected MDMs, we investigated the
involvement of NF-nB and TNF in the modulation of these
anti-apoptotic proteins.ninfected (control) or were infected by HIV-1BaL at day 0 and analyzed for
MSA was carried out in control and infected MDMs. Specific binding was
methods. (B) Fold increase of the activity of NF-nB upon infection was
as determined by titration of p24 in cell supernatants. For B and C, curves
s. Symbols used in both panels refer to the same donors. The data used in
Fig. 4. Effect of HIV-1 infection on TNF production in MDMs. MDMs
were left uninfected (control) or were infected by HIV-1BaL at day 0 and cell
supernatants were collected for analysis of TNF production by ELISA
during 14 days. Data are given with standard deviations for each time point
of the kinetics as a mean of independent assays performed with cells from
five different donors. P value was determined using the nonparametric test
of Mann–Whitney.
E. Guillemard et al. / Virology 329 (2004) 371–380 375TNF produced by MDMs upregulates Bcl-2 and Bcl-xL
expression and prevents apoptosis
We first analyzed the role of TNF in the expression of
Bcl-2 and Bcl-xL by measuring the level of both proteins
by Western blot analysis in MDMs treated with recombi-
nant human TNF. As shown in Fig. 5, TNF induces an
increase in expression of both Bcl-2 and Bcl-xL in MDMs
after 2 or 72 h of treatment (P b 0.04 in three independent
experiments). We then investigated the role of endogenous
TNF produced during infection by analyzing expression of
Bcl-2 and Bcl-xL in HIV-1-infected MDMs cultivated inFig. 5. Effect of recombinant TNF on Bcl-2 and Bcl-xL expression in
MDMs. Control MDMs were first cultivated for 11 days. Cells were then
treated for 2 h with recombinant TNF at 40 ng/ml and were analyzed by
Western Blot for Bcl-2 and Bcl-xL expression in comparison with h-Actin
as a protein of constant expression. The blots presented here are
representative of experiments carried out with cells from three different
donors.the presence of an anti-TNF anti-serum or an inhibitor of
TNF synthesis RP55778 (Le Naour et al., 1994a; Weiss-
man et al., 1993). Our results demonstrate that both the
anti-TNF serum or the inhibitor RP55778 decreased the
expression of both Bcl-2 and Bcl-xL in infected MDMs
(Fig. 6A), with however a higher efficiency for RP55778.
This was confirmed by densitometric analysis in three
independent experiments (P b 0.04, data not shown).
Indeed, RP55778 treatment was shown to markedly
decrease HIV replication (Fig. 6B, left panel). Treatment
with anti-TNF serum induced no significant decrease in
HIV replication (Fig. 6B, right panel), whereas down-
regulation of Bcl-2 and Bcl-xL was observed. Of note, we
did not observed any modulation of the pro-apoptotic
protein Bax either under TNF treatment or in condition of
inhibition of TNF production (data not shown).
We then measured the level of apoptosis of MDMs
treated with RP55778 by TUNEL analysis. As shown inFig. 6. Role of endogenous TNF in the regulation of Bcl-2 and Bcl-xL
expression and apoptosis in HIV-1-infected MDMs. (A) MDMs were
infected by HIV-1BaL and analyzed by Western Blot for Bcl-2 and Bcl-xL
expression in comparison with h-Actin as a protein of constant expression.
Infected cells were cultivated in regular medium or in the presence of the
TNF-synthesis inhibitor RP55778 or an anti-TNF serum. (B) Viral
production was determined by titration of p24 in cell supernatants. (C)
Infected MDMs seeded in Lab-Tek chamber slides and treated or not with
the TNF synthesis inhibitor RP55778 were used for detection of apoptotic
cells by TUNEL analysis. Results are given as apoptotic cell counts per
well, as a mean of duplicate with standard deviation. The data presented
here are representative of two (C) to three (A and B) experiments carried
out with cells from different donors.
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cells in infected MDMs. This was shown both by TUNEL
labeling and by the presence of nuclear apoptotic bodies in
Hoechst-counterstained cells (data not shown). Therefore,
downregulation of the anti-apoptotic molecules Bcl-2 and
Bcl-xL in the presence of RP55778 was associated with an
increase of apoptosis. Thus, TNF produced upon infection is
involved in the positive control of expression of both Bcl-2
and Bcl-xL, which prevents apoptosis in infected MDM.
This increase in expression of the anti-apoptotic proteins
was diminished when the anti-TNF serum was used (see
Discussion).
TNF-induced NF-kB activity is involved in positive
regulation of Bcl-xL but not of Bcl-2
We then determined whether TNF-induced NF-nB
activity was involved in the regulation of Bcl-2 or Bcl-xL
expression. For this purpose, we first measured the
activation level of NF-nB activity in the presence of anti-
TNF serum or RP55778, as described above. Our results
show that NF-nB activity in infected macrophages was
decreased in both conditions (Fig. 7A), confirming the role
of TNF in the induction of this activity.
Bcl-2 and Bcl-xL proteins were then detected in
MDMs treated with sesquiterpene lactone, which prevents
the degradation of InB inhibitory molecules through
inhibition of the IKK activity (Hehner et al., 1998,
1999). This inhibitor was used at concentrations that did
not induce cytotoxicity (data not shown), as shown by
analysis of Lactate Deshydrogenase release in cell super-
natants. As shown in Fig. 7B, sesquiterpene lactoneFig. 7. Role of NF-nB in the expression of Bcl-2 and Bcl-xL in HIV-1-
infected MDMs. (A) NF-nB activity was measured in infected MDMs
incubated in the presence of the TNF-synthesis inhibitor RP55778 or an
anti-TNF serum. (B) NF-nB activity and Bcl-2 and Bcl-xL expression were
measured in infected MDMs incubated in the presence of various
concentrations of the NF-nB inhibitor, sesquiterpene lactone. Analysis of
NF-nB activity was carried out by EMSA and analysis for Bcl-2 and Bcl-xL
expression was done by Western blot in comparison with h-Actin as a
protein of constant expression. The data presented here are representative of
three experiments carried out with cells from different donors.strongly inhibited NF-nB activity in HIV-infected MDMs
in a dose-dependent manner. This inhibition was accom-
panied by a decrease in Bcl-xL expression that was not
observed for Bcl-2. Rather, sesquiterpene lactone tended to
increase Bcl-2 expression. Therefore, NF-nB is involved in
the positive regulation of Bcl-xL but not of Bcl-2 in HIV-
infected MDMs. Positive regulation of Bcl-2 by TNF is
thus likely mediated by an NF-nB-independent pathway
whereas TNF-induced Bcl-xL expression occurs through an
NF-nB-dependent pathway.Discussion
In the present paper, we investigated the mechanisms
responsible for the high survival capacity of HIV-infected
macrophages that could contribute to the persistent
infection observed in patients. Our in vitro studies
demonstrate that the absence of apoptosis in HIV-1-
infected monocyte-derived macrophages (MDMs) corre-
lates with an increase in the expression of the anti-
apoptotic proteins Bcl-2 and Bcl-xL and a decrease in
expression of the apoptotic proteins Bax and Bad upon
infection. Our data show that this anti-apoptotic pattern is
associated with an increase in the activation state of
MDMs. This was shown by an increased TNF production
upon infection, which in turn induced an increase in NF-
nB activity. By the use of an anti-TNF antiserum and an
inhibitor of TNF synthesis RP55778, we demonstrate that
this increase in TNF production is involved in the
upregulation of both Bcl-2 and Bcl-xL, correlating with a
protection against apoptosis in infected MDMs. In addi-
tion, sesquiterpene lactone, a direct inhibitor of NF-nB
activation, decreases Bcl-xL but not Bcl-2 expression in
HIV-1-infected MDMs. Therefore, TNF-mediated upregu-
lation of Bcl-xL and Bcl-2 expression during infection
occurs, respectively, through an NF-nB-dependent and an
NF-nB-independent pathway. It is of note that RP55778 is
always more efficient than the anti-TNF antiserum in all
the assays we used and particularly in its effect on
apoptosis. We interpret this result as a consequence of
the known dual activity of TNF, which elicits both an anti-
apoptotic activity through NF-nB activation, and a pro-
apoptotic activity through induction of the caspase cascade.
The respective importance of these two pathways regarding
the survival or apoptosis decision varies from one cell type
to another and has not been specifically studied in
macrophages. For example, we showed in mature thymo-
cytes that the thymic microenvironment (IL-7) induces the
expression of TNFR-2, therefore inhibiting apoptosis,
whereas the constitutive TNF-R1 leads to apoptosis
(Guillemard et al., 2001). Under these conditions, inhibit-
ing TNF activity will interfere with both pathways, but the
respective effect of the antiserum on activation of the TNF-
R1 and the TNF-R2 receptors is difficult to predict. In
addition, direct cell to cell transmission of TNF might be
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On the other hand, RP5578 has been shown to inhibit TNF
synthesis, probably at the level of secretion (Le Naour
et al., 1994a), therefore acting before TNF is produced, and
leading to inhibition of all downstream pathways. As
expected, RP55778 has been previously shown in HIV-
infected macrophages to decrease both viral and cytokine
production (Le Naour et al., 1994b).
Regarding sesquiterpene lactone, it has been described
as an inhibitor of the IKK complex, and more recent data
(Zhang et al., in press) suggest that it also acts by
inhibiting TNF-alpha-mediated NF-nB activation via dis-
rupting the recruitment of the IKK complex to the TNF
receptor. The observed effects are consistent with an
inhibitory effect of RP55778 on TNF production and of
sesquiterpene lactone on NF-nB activation. In addition, a
recent paper (Liu et al., 2004) indicates that TNF is
responsible for survival of noninfected macrophages
through induction of NF-nB, which is consistent with the
results presented here.
In a previous report we showed that monocytic U937
cells infected with HIV-1 exhibit transient downregulation
of Bcl-2 expression, which correlates with an increased
apoptosis. Later, during infection, apoptosis decreased due
to HIV-induced upregulation of Bcl-2 at the transcriptional
level, allowing cell survival of HIV-productive cells (Aillet
et al., 1998). A similar pattern of Bcl-2 modulation was
observed in vivo because monocytes from HIV-infected
patients showed transient downregulation of Bcl-2 in the
asymptomatic phase of infection (Elbim et al., 1999). We
report here that, in contrast with the monocytic cell type,
fully differentiated macrophages exhibit a substantial
increase in the expression of the anti-apoptotic proteins
Bcl-2 and Bcl-xL upon HIV infection, with no transient
downmodulation. One of the possible explanations for the
kinetic differences observed between monocytes and
macrophages could be their level of activation, that is,
the induction of NF-nB and TNF, which we demonstrated
here to be responsible for the regulation of anti-apoptotic
factors in macrophages. Indeed, differentiation of mono-
cytes into macrophages was clearly reported to be
accompanied by induction of the p50–p65 and p50–RelB
active forms of NF-nB (Conti et al., 1997; Lewin et al.,
1997). In addition, this higher activation level in macro-
phages correlates with a higher capacity, compared to
monocytes, to produce inflammatory cytokines such as
TNF, as observed here or under inducing conditions such
as LPS treatment (Gessani et al., 1993). In fully activated
macrophages, our data show that the upregulation of anti-
apoptotic factors or the downmodulation of apoptotic
proteins occurs very early during infection.
The particularly high propensity of macrophages to
respond to HIV infection by rapid induction of protective
mechanisms makes these cells a potent persistent viral
reservoir. The fact that during infection, the level of anti-
apoptotic proteins decreased in parallel with the level ofcell activation suggests two hypotheses. The first one is
that the level of Bcl-2–Bcl-xL remained sufficiently high
to be compatible with cell survival and a stabilized virus
production, as we previously showed in U937 cells
(Aillet et al., 1998). The other possibility is that
modulation of expression of these anti-apoptotic factors
might be an early event, crucial for the onset of HIV
production in macrophages, and that other mechanisms
would later be involved in the long-term maintenance of
cell survival.
In conclusion, we identified crucial mechanisms
involved in the survival of HIV-infected primary macro-
phages. The high level of cell activation and the inflamma-
tory context in AIDS patients could therefore participate in
the establishment of this viral reservoir.Materials and methods
Isolation and culture of blood monocyte-derived
macrophages
Human peripheral blood mononuclear cells (PBMCs)
were obtained from healthy donors by centrifugation on a
Ficoll-Hypaque gradient (Pharmacia). Blood monocytes
were obtained by centrifuging PBMCs on a Percoll gradient
(Amersham Pharmacia Biotech). Purified monocytes were
allowed to adhere to plates and differentiate into macro-
phages for 7 days in complete RPMI containing 10% of
human serum AB (SAB) (Valbiotech). These monocyte-
derived macrophages (MDMs) constitute a 95% pure
population as revealed by immunostaining with anti-CD14
(Becton-Dickinson), anti-CD11b, and anti-CD16 antibodies
(Immunotech-Coulter) (Clarkson and Ory, 1988; Passlick
et al., 1989).
Infection of macrophages
Infections were performed either with the HIV-1BaL
strain or the monocytotropic primary isolate HIV-1BXO8
(provided by H. Fleury, Bordeaux 2 University, France).
HIV-1BaL was maintained and HIV-1BXO8 amplified once in
cord blood PBMC cultures. The obtained stock solutions of
viruses were used at a final dilution of 1/100 to limit the
effects of the proteins eventually produced by PBMCs.
Infection of MDMs was performed at J0 (corresponding to
7 days post adherence of monocytes) at a multiplicity of
infection of 103 for 1 h at 37 8C for both viruses. Both
infected and uninfected cells were then washed three times
with RPMI 1640 and put in culture in complete RPMI
supplemented with 15% FCS. For kinetics of infection, the
medium was replaced every 3–4 days. The HIV-1 p24gag
antigen concentration was determined in culture super-
natants using a p24gag antigen detection kit (Coulter HIV-1
p24 antigen assay) according to the instructions of the
manufacturer.
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The following antibodies were used for the detection of
specific human proteins by Western blot: mouse anti g-Actin
(AC-74) (Sigma), mouse anti-Bcl-2 (Bcl-2/100) (BD Phar-
mingen), rabbit anti-Bax, anti-Bcl-xS/L and anti-Caspase-3
(precursor form and p11–p20 subunits) (TEBU-Santa Cruz),
and rabbit anti-Bad (Calbiochem). Anti-mouse and anti-
rabbit IgG conjugated with horseradish peroxidase (HRP)
(Amersham Pharmacia Biotech) were used as a secondary
antibody.
Western blot analysis
Total extracts were performed as follows: macrophages
were directly lysed in culture wells with lysis buffer (0.2%
Triton X-100, 500 mM NaCl, 500 mM Sucrose, 1 mM
EDTA, 0.15 mM Spermine, 0.5 mM Spermidine, 10 mM
HEPES pH 8, 200 AM Phenylmethylsulfonylfluoride, 4 Ag/
ml Pepstatin A, Aprotinine, Chymostatin and Antipain, 110
mM hmercaptoethanol, 1 mM Sodium-Orthovanadate,
50 mM Sodium Fluoride). Twenty micrograms of protein,
measured with Bradford reagent (Bio-rad Laboratories, Ivry
sur Seine, France), were subjected to SDS-PAGE and
transferred to nitrocellulose for immunodetection. This
was performed with the primary and secondary HRP-
conjugated antibodies described above. The antigen–anti-
body complexes were revealed by enhanced chemilumines-
cence (SuperSignal West Pico Chemiluminescent Substrate,
PIERCE).
Electrophoretic mobility shift assay
Total cell extracts were prepared as described above (see
Western blot), and EMS was performed using the following
NF-nB binding sequence: 5V GACAGAGGGGGA-
CTTTCCGAGAGG 3V 3VGTCTCCCCCTGAAAGG-
GCTCTCCCT 5V in which the NF-nB consensus
binding sequence is indicated in bold. To identify the
subunits constituting NF-nB complexes, specific antibodies
against p50, p65, and Rel B were used in supershifting
experiments.
Densitometric analysis
Densitometric analysis of the autoradiograms (under
conditions of nonsaturating signals in the linear range of
measure) for both EMSA and Western blot was carried
out with a Gene Genius GG system imager (Ozyme-
Syngene). Changes in the expression of factors of interest
were determined by densitometric analysis for each
kinetic time point as a ratio equal to factor level in
infected cells/factor level in control cells. In this ratio
analysis, factor levels (for Bcl-2, Bcl-xL, Bax, or Bad)
were previously divided for standardization with the
corresponding h-Actin level as a protein whose expres-
sion does not change.Measurement of apoptosis and cytotoxicity
For measurement of apoptosis, macrophages were put in
culture in Lab-Tek chamber slides (Nalge Nunc Interna-
tional). Apoptosis was assessed by TUNEL analysis
(Terminal dUTP Nick End Labeled) with Fluorescein-
labeled dUTP (kit from Boehringer Mannheim). Macro-
phages treated with Dnase I type IV (Sigma) were used as
a positive control of DNA fragmentation and all cells were
counterstained with Hoechst (Sigma) for visualization of
total nuclei. Counting of apoptotic cells was carried out
with a Fluorescence Microscope Nikon-Eclipse E600.
Cytotoxicity was assessed by titration of Lactate Deshy-
drogenase release in the cell supernatants (CytoTox 96
Non-Radioactive Cytotoxicity Assay kit, Promega, Madi-
son, WI, USA).
ELISA for TNF
TNF production was quantified in cell supernatants by
ELISA using a Quantikine High Sensitivity kit from R&D
Systems (France).
Recombinant TNF and inhibitors of TNF or NF-kB
activities
Recombinant TNF was provided by TEBU-Peprotech
(Le Perray en Yvelines, France). For inhibition of TNF
activity, a polyclonal rabbit antihuman TNF serum kindly
provided by Dr. J.-M Cavaillon (Pasteur Institute, Paris,
France) was used at 1/300 final dilution. RP55778 was also
used at 1 mM and was kindly provided by Dr. Y. He´nin
(Aventis, Paris, France). This compound was shown to act
as an inhibitor of TNF synthesis at a post-transcriptional
level (Le Naour et al., 1994a). Sesquiterpene Lactone was
used as an inhibitor of NF-nB activity (Hehner et al.,
1998). Each compound was added to the MDM culture
medium at the time of infection and every 3–4 days
throughout the time of culture.
Statistical analysis
Statistical analyses were performed using the nonpara-
metric test of Mann–Whitney. The level of significance was
set at P b 0.05.Acknowledgments
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